Medical News
Hypertonic Saline or Carbocisteine in Bronchiectasis
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 614-616, February 5, 2026.
Spontaneous Heparin-Induced Thrombocytopenia after Total Hip Arthroplasty
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 612-614, February 5, 2026.
A Matter of Time
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 589-595, February 5, 2026.
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 619-620, February 5, 2026.
Beta-Blockers after Myocardial Infarction - Toward Personalized Management
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 599-602, February 5, 2026.
The Inherited Basis of Coronary Artery Disease
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 576-587, February 5, 2026.
Sacituzumab Govitecan in Advanced Triple-Negative Breast Cancer
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 620-621, February 5, 2026.
Exploring a New Reef in Dyslipidemic Risk Reduction
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 597-599, February 5, 2026.
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 529-539, February 5, 2026.
Freedom of Speech and the Viability of Science - Dr. Jeremiah Stamlers Fight against HUAC
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 606-611, February 5, 2026.
Elective Cesarean Section for Maternal Preference
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 603-605, February 5, 2026.
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 621-622, February 5, 2026.
Functional Dyspepsia
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Volume 394, Issue 6, Page 624-624, February 5, 2026.
Antigenic Drift and Antivaccine Shift in the 2025-2026 Influenza Season
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Ahead of Print.
The Growing Success of Medicare Drug-Price Negotiation
New England Journal of Medicine - 4 Feb 2026 10:00
New England Journal of Medicine, Ahead of Print.